More recent swine vesicular disease virus isolates retain binding to coxsackie - Adenovirus receptor, but have lost the ability to bind human decay-accelerating factor (CD55)

Journal of General Virology

Volumn 86, Issue 5, 2005, Pages 1369-1377

  Jimenez Clavero, Miguel A ^a,c   Escribano Romero, Estela ^a   Ley, Victoria ^a   Spiller, O Brad ^b  

^a Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria   (Spain)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c Laboratorio Central de Veterinaria   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; DECAY ACCELERATING FACTOR; PROTEIN ANTIBODY;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; EPIDEMIC; HELA CELL; HUMAN; HUMAN CELL; ISOTOPE LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVIRUS; RECEPTOR BINDING; SWINE; SWINE VESICULAR EXANTHEMA VIRUS; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS TITRATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD55; CELLS, CULTURED; ENTEROVIRUS B, HUMAN; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, VIRUS; SWINE;

ADENOVIRIDAE; HUMAN ENTEROVIRUS B; SUS SCROFA; SWINE VESICULAR DISEASE VIRUS;

EID: 18144381153     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.80669-0     Document Type: Article

References (37)

1. Bergelson, J. M., Chan, M., Solomon, K. R., St John, N. F., Lin, H. & Finberg, R. W. (1994). Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci U S A 91, 6245-6248.
2. Bergelson, J. M., Mohanty, J. G., Crowell, R. L., St John, N. F., Lublin, D. M. & Finberg, R. W. (1995). Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol 69, 1903-1906.
3. Bergelson, J. M., Modlin, J. F., Wieland-Alter, W., Cunningham, J. A., Crowell, R. L. & Finberg, R. W. (1997). Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J Infect Dis 175, 697-700.
4. Borrego, B., Carra, E., García-Ranea, J. A. & Brocchi, E. (2002). Characterization of neutralization sites on the circulating variant of swine vesicular disease virus (SVDV): a new site is shared by SVDV and the related coxsackie B5 virus. J Gen Virol 83, 35-44.
5. Brocchi, E., Zhang, G., Knowles, N. J., Wilsden, G., McCauley, J. W., Marquardt, O., Ohlinger, V. F. & De Simone, F. (1997). Molecular epidemiology of recent outbreaks of swine vesicular disease: two genetically and antigenically distinct variants in Europe, 1987-94. Epidemiol Infect 118, 51-61.
6. Brown, F., Talbot, P. & Burrows, R. (1973). Antigenic differences between isolates of swine vesicular disease virus and their relationship to coxsackie B5 virus. Nature 245, 315-316.
7. Clarkson, N. A., Kaufman, R., Lublin, D. M., Ward, T., Pipkin, P. A., Minor, P. D., Evans, D. J. & Almond, J. W. (1995). Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding. J Virol 69, 5497-5501.
8. de Castro, M. P. (1964). Behaviour of the foot-and-mouth disease virus in cell cultures: susceptibility of the IB-RS-2 cell line. Arq Inst Biol Sao Paulo 31, 63-78.
9. Dekker, A., Moonen, P., de Boer-Luijtze, E. A. & Terpstra, C. (1995). Pathogenesis of swine vesicular disease after exposure of pigs to an infected environment. Vet Microbiol 45, 243-250.
10. Escribano-Romero, E., Jimenez-Clavero, M. A. & Ley, V. (2000). Swine vesicular disease virus. Pathology of the disease and molecular characteristics of the virion. Anim Health Res Rev 1, 119-126.
11. Escribano-Romero, E., Jimenez-Clavero, M. A., Gomes, P., García-Ranea, J. A. & Ley, V. (2004). Heparan sulphate mediates swine vesicular disease virus attachment to the host cell. J Gen Virol 85, 653-663.
12. Espuña, E., Alemany, R., Riera, P., Artigas, C., Rosell, R., Pujols, J., Sanmartín, J. & San Gabriel, A. (1993). Aislamiento del virus de la enfermedad vesicular porcina en España. Med Vet 10, 657-662 (in Spanish).
13. Fry, E. E., Knowles, N. J., Newman, J. W. I., Wilsden, G., Rao, Z., King, A. M. Q. & Stuart, D. I. (2003). Crystal structure of swine vesicular disease virus and implications for host adaptation. J Virol 77, 5475-5486.
14. Graves, J. H. (1973). Serological relationship of swine vesicular disease virus and coxsackie B5 virus. Nature 245, 314-315.
15. Harris, C. L., Spiller, O. B. & Morgan, B. P. (2000). Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities. Immunology 100, 462-470.
16. He, Y., Chipman, P. R., Howitt, J. & 7 other authors (2001). Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol 8, 874-878.
17. He, Y., Lin, F., Chipman, P. R., Bator, C. M., Baker, T. S., Shoham, M., Kuhn, R. J., Medof, M. E. & Rossmann, M. G. (2002). Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex. Proc Natl Acad Sci U S A 99, 10325-10329.
18. Inoue, T., Yamaguchi, S., Kanno, T., Sugita, S. & Saeki, T. (1993). The complete nucleotide sequence of a pathogenic swine vesicular disease virus isolated in Japan (J1′73) and phylogenetic analysis. Nucleic Acids Res 21, 3896.
19. Jiménez-Clavero, M. A., Escribano-Romero, E., Sánchez-Vizcaíno, J. M. & Ley, V. (1998). Molecular cloning, expression and immunological analysis of the capsid precursor polypeptide (P1) from swine vesicular disease virus. Virus Res 57, 163-170.
20. Karnauchow, T. M., Tolson, D. L., Harrison, B. A., Altman, E., Lublin, D. M. & Dimock, K. (1996). The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J Virol 70, 5143-5152.
21. Karnauchow, T. M., Dawe, S., Lublin, D. M. & Dimock, K. (1998). Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding. J Virol 72, 9380-9383.
22. Knowles, N. J. & McCauley, J. W. (1997). Coxsackievirus B5 and the relationship to swine vesicular disease virus. Curr Top Microbiol Immunol 223, 153-167.
23. Martino, T. A., Petric, M., Weingartl, H. & 9 other authors (2000). The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology 271, 99-108.
24. Nardelli, L., Lodetti, E., Gualandi, G. L., Burrows, R., Goodridge, D., Brown, F. & Cartwright, B. (1968). A foot and mouth disease syndrome in pigs caused by an enterovirus. Nature 219, 1275-1276.
25. Pérez de la Lastra, J. M., Harris, C. L., Hinchliffe, S. J., Holt, D. S., Rushmere, N. K. & Morgan, B. P. (2000). Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats. J Immunol 165, 2563-2573.
26. Seechurn, P., Knowles, N. J. & McCauley, J. W. (1990). The complete nucleotide sequence of a pathogenic swine vesicular disease virus. Virus Res 16, 255-274.
27. Shafren, D. R., Bates, R. C., Agrez, M. V., Herd, R. L., Burns, G. F. & Barry, R. D. (1995). Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol 69, 3873-3877.
28. Shafren, D. R., Dorahy, D. J., Ingham, R. A., Burns, G. F. & Barry, R. D. (1997). Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J Virol 71, 4736-4743.
29. Spiller, O. B., Goodfellow, I. G., Evans, D. J., Almond, J. W. & Morgan, B. P. (2000). Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF. J Infect Dis 181, 340-343.
30. Spiller, O. B., Goodfellow, I. G., Evans, D. J., Hinchliffe, S. J. & Morgan, B. P. (2002). Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF. J Gen Virol 83, 45-52.
31. Stuart, A. D., McKee, T. A., Williams, P. A., Harley, C., Shen, S., Stuart, D. I., Brown, T. D. K. & Lea, S. M. (2002). Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection. J Virol 76, 7694-7704.
32. Verdaguer, N., Jimenez-Clavero, M. A., Fita, I. & Ley, V. (2003). Structure of swine vesicular disease virus: mapping of changes occurring during adaptation of human coxsackie B5 virus to infect swine. J Virol 77, 9780-9789.
33. Ward, T., Pipkin, P. A., Clarkson, N. A., Stone, D. M., Minor, P. D. & Almond, J. W. (1994). Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J 13, 5070-5074.
34. Yanagawa, B., Spiller, O. B., Choy, J. & 8 other authors (2003). Coxsackievirus B3-associated myocardial pathology and viral load reduced by recombinant soluble human decay-accelerating factor in mice. Lab Invest 83, 75-85.
35. Yanagawa, B., Spiller, O. B., Proctor, D. G., Choy, J., Luo, H., Zhang, H. M., Suarez, A., Yang, D. & McManus, B. M. (2004). Soluble recombinant coxsackie and adenovirus receptor abrogates coxsackievirus B3-mediated pancreatitis and myocarditis in mice. J Infect Dis 189, 1431-1439.
36. Zhang, G., Wilsden, G., Knowles, N. J. & McCauley, J. W. (1993). Complete nucleotide sequence of a coxsackie B5 virus and its relationship to swine vesicular disease virus. J Gen Virol 74, 845-853.
37. Zhang, G., Haydon, D. T., Knowles, N. J. & McCauley, J. W. (1999). Molecular evolution of swine vesicular disease virus. J Gen Virol 80, 639-651.